HKB's Mouse Liver Fibrosis Models provide pharmaceutical researchers with robust platforms for investigating hepatic fibrogenesis and testing anti-fibrotic interventions. Our validated rodent models utilize chronic CCl4 administration, bile duct ligation, or methionine-choline-deficient diet to replicate progressive stages of liver fibrosis.